Tag: Zepbound
Eli Lilly is considering offering more Zepbound doses in vials at lower cost
Eli Lilly's move to offer lower-priced vials of its obesity drug Zepbound was seen as a step towards…
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The introduction of the anti-obesity drug Zepbound by Eli Lilly & Co. is projected to have a significant…
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The Food and Drug Administration (FDA) recently approved Eli Lilly's obesity drug Zepbound, also known as tirzepatide, as…
More state Medicaid programs may soon cover Wegovy, Zepbound
State Medicaid programs have historically not covered the new class of weight loss drugs for obesity, but recent…
Obesity drug tracker: Can amylin drugs upend Wegovy, Zepbound?
Related feature: STAT’s Obesity Drug Tracker, updated and with a new feature that allows the entire dataset to…
Here Are Other Conditions Ozempic, Wegovy, Mounjaro, Zepbound May Successfully Treat
The class of drugs that includes popular medications like Ozempic, Wegovy, Rybelsus (semaglutide) or Mounjaro and Zepbound (tirzepatide)…
Lilly’s Zepbound price cut could help customers — and boost profits
Overall, while Lilly’s move to offer discounted vials of Zepbound may seem like a positive step towards increasing…